DR.MAX secures contract for Anthelmintics - PURCHASE OF MEDICINES WITHIN THE NATIONAL PROGRAM OF "DIAGNOSTIC AND TREATMENT FOR RARE DISEASES MUCOPOLYSACHARIDOSIS TYPE II (HUNTER SYNDROME)"

Romania, Dec. 10 -- Romania based DR.MAX has secured contract from Operator SEAP for Anthelmintics - PURCHASE OF MEDICINES WITHIN THE NATIONAL PROGRAM OF "DIAGNOSTIC AND TREATMENT FOR RARE DISEASES MUCOPOLYSACHARIDOSIS TYPE II (HUNTER SYNDROME)". The value of the contract is worth 44947716 RON.

Published by HT Digital Content Services with permission from Pivotal Sources....